Pharmacological treatment of violence in schizophrenia
Chronic aggression and violence in schizophrenia are rare, but receive disproportionate negative media coverage. This contributes to the stigma of mental illness and reduces accessibility to mental health services. Substance Use Disorders (SUD), antisocial behavior, non-adherence and recidivism are known risk factors for violence. Treatment with antipsychotic medication can reduce violence. Aside from clozapine, long-acting injectable antipsychotics (LAI) appear to be superior to oral antipsychotics for preventing violence, addressing adherence and recidivism. LAI also facilitate the implementation of functional skills training. For the high-risk recidivist target population with schizophrenia, better life skills have the potential to also reduce the risk for contact with the legal system, including an improved ability to live independently in supported environments and interact appropriately with others. High-risk patients who are resistant to treatment with other antipsychotics should receive treatment with clozapine due to its direct positive effects on impulsive violence, along with a reduction in comorbid risk factors such as SUDs.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:25 |
|---|---|
| Enthalten in: |
CNS spectrums - 25(2020), 2 vom: 28. Apr., Seite 207-215 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Strassnig, Martin T [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Aggressive behavior |
|---|
| Anmerkungen: |
Date Completed 01.07.2021 Date Revised 01.07.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1017/S1092852919001226 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM299548937 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM299548937 | ||
| 003 | DE-627 | ||
| 005 | 20231225100557.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1017/S1092852919001226 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0998.xml |
| 035 | |a (DE-627)NLM299548937 | ||
| 035 | |a (NLM)31342892 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Strassnig, Martin T |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Pharmacological treatment of violence in schizophrenia |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.07.2021 | ||
| 500 | |a Date Revised 01.07.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Chronic aggression and violence in schizophrenia are rare, but receive disproportionate negative media coverage. This contributes to the stigma of mental illness and reduces accessibility to mental health services. Substance Use Disorders (SUD), antisocial behavior, non-adherence and recidivism are known risk factors for violence. Treatment with antipsychotic medication can reduce violence. Aside from clozapine, long-acting injectable antipsychotics (LAI) appear to be superior to oral antipsychotics for preventing violence, addressing adherence and recidivism. LAI also facilitate the implementation of functional skills training. For the high-risk recidivist target population with schizophrenia, better life skills have the potential to also reduce the risk for contact with the legal system, including an improved ability to live independently in supported environments and interact appropriately with others. High-risk patients who are resistant to treatment with other antipsychotics should receive treatment with clozapine due to its direct positive effects on impulsive violence, along with a reduction in comorbid risk factors such as SUDs | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Clozapine | |
| 650 | 4 | |a aggressive behavior | |
| 650 | 4 | |a institutionalization | |
| 650 | 4 | |a long-acting injectable antipsychotic | |
| 650 | 4 | |a recidivism | |
| 650 | 4 | |a relapse | |
| 650 | 4 | |a violence | |
| 650 | 7 | |a Antipsychotic Agents |2 NLM | |
| 700 | 1 | |a Nascimento, Vanessa |e verfasserin |4 aut | |
| 700 | 1 | |a Deckler, Elizabeth |e verfasserin |4 aut | |
| 700 | 1 | |a Harvey, Philip D |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t CNS spectrums |d 1998 |g 25(2020), 2 vom: 28. Apr., Seite 207-215 |w (DE-627)NLM096422688 |x 1092-8529 |7 nnns |
| 773 | 1 | 8 | |g volume:25 |g year:2020 |g number:2 |g day:28 |g month:04 |g pages:207-215 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1017/S1092852919001226 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 25 |j 2020 |e 2 |b 28 |c 04 |h 207-215 | ||